The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Immutep Limited(NASDAQ:IMMP) 
Immutep Limited, a biotech company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its principal product candidate is IMP321, also known as ?eftilagimod alpha' or ?efti...
Immutep Days Payable Outstanding ttm (DPO)
Immutep Days Receivable Outstanding ttm (DSO)
Immutep Days Inventory Outstanding ttm (DIO)
Immutep Op Cashflow Per Share ttm
Immutep Free Cashflow Per Share ttm
Immutep Cash Per Share ttm
Immutep P/S ratio ttm
Immutep (GAAP) P/E ratio ttm
Immutep P/B ratio ttm
No extra charts and metrics for this ticker.